Area of research
Genetics · Oncology
Research interest
Research interests include CAR-T cell therapy research, Glioma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, and Immune cells in cancer.
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors.
Microglial fructose metabolism is essential for glioblastoma growth.
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models.
Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell-Engaging Antibody in GBM via Passive and Active Mechanisms.
Data from Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms
Supplementary Data1 from Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms
Microglial Fructose Metabolism Is Essential for Glioblastoma Growth
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy
Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas.
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment.
Cyanine lipids promote the shedding of extracellular vesicles from cell membranes
Supplementary Data from Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Supplementary Data from Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Data from Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Data from Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs
Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs.
Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs
Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma
Ribosomal protein S11 influences glioma response to TOP2 poisons
Heterogeneity and vascular permeability of breast cancer brain metastases.
Neural Stem Cells Secreting Bispecific T Cell Engager to Induce Selective Anti-Glioma Activity
Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma
Interaction between DNA damage response, translation and apoptosome determines cancer susceptibility to TOP2 poisons
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression